Genex Pharmaceutical, Inc. (GENX) Comparison with companies in other sectors?

Genex Pharmaceutical, Inc. has a share price of 17.85M. You can analyze Genex Pharmaceutical, Inc. (GENX) competitors across different market sectors through stock heatmaps.

What are GENX's NET and operating margins?

Genex Pharmaceutical, Inc. (GENX) operating margin is around 0.14, and net profit margin is approximately 0.11 as of the latest reports.

In what way does GENX's earnings per share (EPS) trend reflect its financial momentum?

Genex Pharmaceutical, Inc. (GENX) EPS is 0.02 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Genex Pharmaceutical, Inc. is 0.01, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Genex Pharmaceutical, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Genex Pharmaceutical, Inc. like P/E which is 0.00, P/B which is 0.00, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Genex Pharmaceutical, Inc.

GENX•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$0.00

$0.00(0.00%)

Genex Pharmaceutical, Inc. (GENX) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.02

P/E Ratio

0.01

ROE

0.08%

Net Margin

0.11%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.78K

Shares OutstandingTotal number of shares issued

$17.85M

Book Value/ShareNet worth per share

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.02

Net MarginNet income as percentage of revenue

10.58%

Operating MarginOperating income as percentage of revenue

14.40%

ROEReturn on shareholders' equity

7.78%

ROAReturn on total assets

3.96%

ROCEReturn on capital employed

9.01%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

29602.52%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for GENXFinancial Ratios Analysis details for GENX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for GENXSector Benchmarking details for GENX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Genex Pharmaceutical, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Genex Pharmaceutical, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Genex Pharmaceutical, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Genex Pharmaceutical, Inc.

For Genex Pharmaceutical, Inc., essential financial indicators include EPS 0.02, PE 0.01, and ROE 0.08. These key ratios reveal insights into Genex Pharmaceutical, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Genex Pharmaceutical, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Genex Pharmaceutical, Inc.

Metrics like Net Margin 10.58% and ROA 3.96% shed light on how well Genex Pharmaceutical, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Genex Pharmaceutical, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Genex Pharmaceutical, Inc.

Using ratios such as P/B Ratio - and PEG Ratio -, investors can assess whether Genex Pharmaceutical, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Genex Pharmaceutical, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Genex Pharmaceutical, Inc.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow -, provide a snapshot of Genex Pharmaceutical, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Genex Pharmaceutical, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Genex Pharmaceutical, Inc.

Investing in Genex Pharmaceutical, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Genex Pharmaceutical, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;